Legal Representation
Attorney
Claudia A. Smith
USPTO Deadlines
Application History
11 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Apr 9, 2019 | ABN1 | O | ABANDONMENT - EXPRESS MAILED | Loading... |
| Apr 9, 2019 | MAB1 | E | ABANDONMENT NOTICE E-MAILED - EXPRESS ABANDONMENT | Loading... |
| Apr 8, 2019 | EXAR | I | TEAS EXPRESS ABANDONMENT RECEIVED | Loading... |
| Mar 28, 2019 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Mar 28, 2019 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Mar 28, 2019 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Mar 22, 2019 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Mar 21, 2019 | MDSC | E | NOTICE OF DESIGN SEARCH CODE E-MAILED | Loading... |
| Mar 20, 2019 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Feb 7, 2019 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Jan 18, 2019 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Vaccines; pharmaceutical preparations and substances for the prevention and treatment of disorders and diseases in, generated by or acting on the central nervous system; pharmaceutical preparations and substances acting on the central nervous system; central nervous system stimulants; pharmaceutical preparations and substances for the prevention and treatment of psychiatric and neurological disorders and diseases; pharmaceutical preparations and substances for the prevention and treatment of dementia, Alzheimer's disorder and disease, dizziness, seizures, stroke, depression, cognitive impairment, cognitive disorders and diseases, mood disorders, psychosis, anxiety, apathy, epilepsy; pharmaceutical preparations and substances for the prevention and treatment of Lennox-Gastaut syndrome (LGS), sclerosis, porphyria, Huntington's disorder and disease, insomnia, Parkinson's disorder and disease, falls, movement disorders and diseases, dyskinesia, poor or absent motor functions, tremor, schizophrenia, bipolar disorder and disease, mania, ADHD, PTSD, agitation, aggression, autism, melancholy, OCD, Tourette's syndrome, progressive supranuclear palsy (PSP), restlessness, akathisia, fatigue, somnolence, nausea, cancer, migraine, pain, alcoholism and chemical dependency; diagnostic agents, reagents, preparations and substances for medical purposes
First Use Anywhere:
0
First Use in Commerce:
0
Additional Information
Design Mark
The mark consists of a white rectangle with two bands in yellow and blue aligned separately and horizontally and creating a white band with the underlined word LUNDBECK in stylized font in grey to the left of a red starfish and appearing on the white band.
Color Claim
The color(s) white, yellow, blue, grey and red is/are claimed as a feature of the mark.
Classification
International Classes
005